Development
Lantern Pharma Inc.
LTRN
$4.99
-$0.15-2.92%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -22.31% | -22.85% | -20.97% | -21.96% | -21.68% |
| Total Receivables | -- | -- | -- | 227.07% | 329.58% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 63.32% | 40.08% | 139.61% | -26.36% | -28.52% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -71.99% | -33.20% | 32.84% | 179.52% | 192.10% |
| Total Current Assets | -23.53% | -22.27% | -18.47% | -19.24% | -18.75% |
|
|
|||||
| Total Current Assets | -23.53% | -22.27% | -18.47% | -19.24% | -18.75% |
| Net Property, Plant & Equipment | 152.33% | 127.14% | 71.27% | -55.74% | -49.66% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 44.69% | -95.37% | -94.10% | -98.24% | -98.24% |
| Total Assets | -23.15% | -22.53% | -18.85% | -20.44% | -19.90% |
|
|
|||||
| Total Accounts Payable | 59.16% | -15.77% | 71.80% | 36.90% | 36.45% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 82.61% | 24.79% | -22.94% | -65.22% | -38.26% |
| Total Finance Division Other Current Liabilities | -74.96% | -63.43% | -33.26% | 21.43% | 125.49% |
| Total Other Current Liabilities | -74.96% | -63.43% | -33.26% | 21.43% | 125.49% |
| Total Current Liabilities | -28.22% | -43.14% | -9.13% | 20.29% | 75.80% |
|
|
|||||
| Total Current Liabilities | -28.22% | -43.14% | -9.13% | 20.29% | 75.80% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 957.14% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -24.82% | -40.30% | -4.97% | 17.62% | 67.18% |
|
|
|||||
| Common Stock & APIC | 1.31% | 1.43% | 1.32% | -1.03% | -2.01% |
| Retained Earnings | -42.22% | -42.39% | -48.06% | -56.99% | -67.12% |
| Treasury Stock & Other | 68.09% | 24.88% | 3.79% | -300.65% | -323.56% |
| Total Common Equity | -23.06% | -20.98% | -19.51% | -21.70% | -22.06% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -23.06% | -20.98% | -19.51% | -21.70% | -22.06% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -23.06% | -20.98% | -19.51% | -21.70% | -22.06% |
|
|
|||||